Current issue


May 2014

Volume 63

Issue 5

Impact factor: 10.732

Gut is a leading international journal in gastroenterology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage of all areas in gastroenterology. Regular features include articles by leading authorities, reports on the latest treatments for diseases, reviews and commentaries.Subscribers to Gut also receive Frontline Gastroenterology (FG). Gut has retained its 3rd position ranking in the category of the Gastroenterology and Hepatology with a new impact factor of 10.732. Did you know that your manuscript will be reviewed by Gut editors within 16 days? Submit here >>

IBD Special Issue

Now freely available online only - a special IBD Gut issue, read about the most recent advances in both basic and clincial IBD science:

IBD Special Issue >>

Follow us on Twitter

Keep up to date with the latest Editor's choice, News and Open Access articles @Gut_BMJ:

Follow us on Twitter >>

Find us on Facebook >>

This Months Free Hot topic

This month Gut evaluates the safety and pharmacology of etrolizumab in patients with moderate to severe ulcerative colitis

A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis >>

Mobile Site

All mobile users are now automatically forwarded to an optimised web interface when visiting Gut

View the mobile site >>
More information >>